Clinical trial NCT06252831 - References

Dysbacteriosis — Study of the Safety and Tolerability of the Broad-spectrum Probiotic Medicine "AS-Probionorm"

Citation(s)

•   A
  K. Sadanov, N.N. Gavrilova, I.A. Ratnikova, S.E. Orazymbet, E.Zh. Shorabayev, Zh.T. Musabekov, R.Zh. Kaptagay, L.E. Protasyuk, L.A. Kosheleva, S.B. Dzhailyauova Association of bacteria for the production of a medicinal probiotic preparation with a wide spectrum of antimicrobial action // Microbiology and virology. - ISSN 2304-585X. - No. 1 (40) 2023. -- pp. 116-126. - doi: 10.53729/MV-AS.2023.01.07; IF-0.038.
•   A
  K. Sadanov, N.N. Gavrilova, I.A. Ratnikova, S.E. Orazymbet, L.E. Protasiuk, A.D. Massirbaeva Technology for the production of Lyophilizate of an association of Lactic acid bacteria included in the Medicinal product AS-Probionorm // Research J. Pharm. and Tech. 16(11):5334-5340. - November 2023. - DOI: 10.52711/0974-360X.2023.00864. - ISSN 0974-3618 (Print), 0974-360X (Online). Q2, 56th percentile.
•   Sadanov A
  K., Gavrilova N.N., Ratnikova I.A., Orazymbet S.E., Shorabayev E.Zh., Protasyuk L.E. Antimicrobial activity of the therapeutic and prophylactic probiotic drug "AS-Probionorm" // Proc. on Sat. mater. Intl. scientific-practical conf. "Biotechnology and biological safety: achievements and development prospects", dedicated to the 65th anniversary of the Research Institute for Biological Safety Problems. - Almaty. - September 6-8, 2023 - P. 134. - UDC 57/60 BBK 28/30.16 B63. ISBN 978-601-305-533-6.

Study of the Safety and Tolerability of the Broad-spectrum Probiotic Medicine "AS-Probionorm" Against Human Intestinal Infections in Healthy Volunteers Produced by Industrial Microbiology LLP (Phase 1)

Details for clinical trial NCT06252831